MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 401 to 420 of 30,876 approvalsPage 21 of 1544

Mucunxt

Issued: Jul 31, 2023

Rapcenate

Issued: Jul 31, 2023

Salbux Plus

Issued: Jul 31, 2023

Estolax

Issued: Jul 31, 2023

Allecur Plus

Issued: Jul 31, 2023

Reverse

Issued: Jul 31, 2023

Spirenze

Issued: Jul 31, 2023

TGP Aces

Issued: Jul 31, 2023
Northfield Laboratories, Inc.

Ciprotam

Issued: Jul 31, 2023
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)

Armadart

Issued: Jul 31, 2023

Metrogil

Issued: Jul 31, 2023

Zarphil

Issued: Jul 31, 2023

Jadelle

Issued: Jul 31, 2023

Ciproquin

Issued: Jul 31, 2023

Lastacaft

Issued: Jul 31, 2023

Zerzime

Issued: Jul 31, 2023

None

Issued: Jul 31, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.